Compass Pathways Equity 2025

Compass Pathways Aktienanalyse

What does Compass Pathways do?

Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Compass Pathways's Equity

Compass Pathways's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Compass Pathways's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Compass Pathways's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Compass Pathways's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Compass Pathways’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Compass Pathways stock

What is the equity of Compass Pathways this year?

Compass Pathways has equity of 154.7 M USD this year.

What was the equity of Compass Pathways compared to the previous year?

The equity of Compass Pathways has increased/decreased by -31.47% decreased compared to the previous year.

What impact does a high equity have on investors of Compass Pathways?

A high equity is advantageous for investors of Compass Pathways as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Compass Pathways?

A low equity can be a risk for investors of Compass Pathways, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Compass Pathways affect the company?

An increase in equity of Compass Pathways can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Compass Pathways affect the company?

A reduction in equity of Compass Pathways can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Compass Pathways?

Some factors that can affect the equity of Compass Pathways include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Compass Pathways so important for investors?

The equity of Compass Pathways is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Compass Pathways take to change the equity?

To change equity, Compass Pathways can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Compass Pathways pay?

Over the past 12 months, Compass Pathways paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compass Pathways is expected to pay a dividend of 0 USD.

What is the dividend yield of Compass Pathways?

The current dividend yield of Compass Pathways is .

When does Compass Pathways pay dividends?

Compass Pathways pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Compass Pathways?

Compass Pathways paid dividends every year for the past 0 years.

What is the dividend of Compass Pathways?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Compass Pathways located?

Compass Pathways is assigned to the 'Health' sector.

Wann musste ich die Aktien von Compass Pathways kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Compass Pathways from 7/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/27/2025.

When did Compass Pathways pay the last dividend?

The last dividend was paid out on 7/27/2025.

What was the dividend of Compass Pathways in the year 2024?

In the year 2024, Compass Pathways distributed 0 USD as dividends.

In which currency does Compass Pathways pay out the dividend?

The dividends of Compass Pathways are distributed in USD.